Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: pappy who wrote (609)	4/5/1998 12:56:00 PM
From: pappy	Read Replies (1) \| Respond to of 4140

Food For Thought Regarding VISX news release dated 3/24/98: Additional highlights of VISX's FDA approval include laser removal of the epithelium (commonly called ''no-touch'' PRK) and system innovations such as better ergonomics for intrastromal microkeratome procedures, improved patient fixation, variable pulse frequency up to 10Hz, and other ease-of-use features. The new system is marketed internationally as the VISX STAR S2 Smoothscan(TM) and is capable of treating hyperopia (farsightedness) and hyperopic astigmatism. ------------------------------------------------------------------------------------------------------------- Granted it's a excimer laser, but is No-Touch Hyperopia already here or soon to come? For the whole press release: biz.yahoo.com